About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 1475 record(s)
Req # A-2021-001701
Adverse Drug Reaction (ADR) for FUROSEMIDE. Report number: E2B_04217039.Organization: Health Canada
January 2022
Req # A-2021-001705
Adverse Drug Reactions (ADRs). Report numbers: 944183, 948200, 947996, 948415, 945490, 945585, 945681, 945833, 946033, 946036.Organization: Health Canada
January 2022
Req # A-2021-001712
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-119878-499.Organization: Health Canada
January 2022
Req # A-2021-001736
Adverse Drug Reactions (ADRs) for TUBERCULIN TEST. Report numbers: 000951279, 000946385, 000950097.Organization: Health Canada
January 2022
Req # A-2021-001743
Adverse Drug Reactions (ADRs). Report numbers: 000967789, 000967793, 000967796.Organization: Health Canada
January 2022
Req # A-2015-000243
All records contained in or referenced in all Natural and Non-prescription Health Products Directorate (NHPD) master files referred to by Cambrian Solutions with respect to chicken eggshell membrane, or partially hydrolyzed chicken eggshell membranes, including MF 40396-MF003.Organization: Health Canada
January 2022
Req # A-2016-000167
The clinical and quality evaluation reports/reviews from Health Canada during 1983 - 1996 inclusive for the following product: LUPRON DEPOT (leuprolide acetate) by TAP Pharmaceuticals Inc and any and all of their subsidies and affiliates.Organization: Health Canada
January 2022
Req # A-2016-000241
All documents between Health Canada and the sponsor regarding section 2.3, 2.5, and 2.7 of the Abbreviated New Drug Submissions(s) (ANDS) and Notice(s) of Compliance for SANDOZ TACROLIMUS.Organization: Health Canada
January 2022
Req # A-2020-000771
The Medical Device License Application Form that resulted in the first issuance of a Medical Device Licence for the LAP-BAND ADJUSTABLE GASTRIC BANDING (LAGB) SYSTEM (License No. 12197) medical device; the device first issuance date being September 20, 1999.Organization: Health Canada
January 2022
Req # A-2020-000790
The name of every manufacturer of the LAP-BAND ADJUSTABLE GASTRIC BANDING (LAGB) SYSTEM (License No. 12197) medical device since the device first issuance date, that being September 20, 1999.Organization: Health Canada
January 2022